Forex News

U.S. Weekly Jobless Claims Climb To 219,000

As the closely watched monthly jobs report looms, the Labor Department released a separate report on Thursday showing first-time claims for U.S. unemployment benefits rebounded by more than expected in the week ended October 1st.

RTTNews | 962 days ago

Peloton To Slash Another 500 Jobs: Reports

Fitness equipment maker Peloton Interactive, Inc. (PTON) is reportedly planning to cut about 500 jobs or 12 percent of its remaining workforce. This will be the company's fourth round of layoffs this year as it struggles to return to profit.

RTTNews | 962 days ago

Bay Street Likely To Open On Weak Note

Canadian shares look headed for a weak start on Thursday, tracking weakness in European markets and lower crude oil prices.

RTTNews | 962 days ago

Annovis Bio Says FDA Authorizes Phase 2/3 Trial For Buntanetap In Alzheimer's Disease

Annovis Bio, Inc. (ANVS), a late-stage clinical drug platform company, announced Thursday that the U.S. Food and Drug Administration (FDA) has authorized the Phase 2/3 clinical study of buntanetap in moderate Alzheimer's Disease (AD).

RTTNews | 962 days ago

Conagra Brands Reaffirms FY23 Outlook - Update

While reporting financial results for the first quarter on Thursday, branded food company Conagra Brands, Inc. (CAG) reaffirmed its adjusted earnings and organic net sales growth guidance for the full-year 2023.

RTTNews | 962 days ago

Euro Edges Down After ECB Minutes

The European Central Bank has published the account of the monetary policy meeting of the Governing Council held on September 7 and 8 at 7:30 am ET Thursday. After the release, the euro edged down against its major rivals.

RTTNews | 962 days ago

Entera Bio Inks Deal With FDA For Single Phase 3 Trial To Support NDA For EB613 For Osteoporosis

Entera Bio Ltd. (ENTX), a developer orally delivered peptides and therapeutic proteins, announced Thursday the successful conclusion of its Type C meeting and agreement from the U.S. Food and Drug Administration (FDA) that a single Phase 3 placebo-controlled study could support a New Drug Application (NDA) submission of EB613 (oral hPTH (1-34), teriparatide tablets) under the 505(b)(2) regulatory pathway.

RTTNews | 962 days ago

more news

Euro Mixed Ahead Of ECB Minutes

The European Central Bank publishes the account of the monetary policy meeting of the Governing Council held on September 7 and 8 at 7:30 am ET Thursday. Ahead of the release, the euro showed mixed trading against its major rivals. While it rose against the franc and the pound, it held steady against the greenback and the yen.

RTTNews | 962 days ago

AngioDynamics Q1 Results Miss Estimates; Reaffirms FY23 Outlook

While reporting financial results for the first quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) reaffirmed its adjusted earnings and net sales guidance for the full year 2023.

RTTNews | 962 days ago

Sensex, Nifty End Off Day's Highs; Metal Stocks Surge

Indian shares pared some early gains to end modestly higher on Thursday, tracking mixed global cues and a surge in international oil prices after OPEC and non-OPEC partners agreed to cut supply by 2 million barrels per day (bpd), which is equal to 2 percent of the global supply.

RTTNews | 962 days ago